Inogen | INGN - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Accuray USD 199.44M 4.83M 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 106.93M 14.23M 2026-06
AtriCure USD 81.92M 8.72M 2026-06
Baxter International USD 3.59B 102M 2026-06
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Cooper Companies USD 1.8B 209M 2026-03
Dexcom USD 2.36B 133.9M 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Globus Medical USD 479.35M 3.12M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 744.2M 56.7M 2026-06
Medtronic USD 11.66B 2.16B 2026-03
Orthofix International USD 157.01M 4.02M 2026-06
Philips EUR 7.42B 8M 2026-06
ResMed USD 1.4B 43.9M 2026-06
Steris USD 1.28B 138.3M 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
X T L Biopharmaceuticals USD 420K 341K 2025-12
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06